Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 6 | 2025 | 380 | 2.000 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2024 | 22 | 0.860 |
Why?
|
| Coronary Angiography | 1 | 2025 | 261 | 0.840 |
Why?
|
| Computed Tomography Angiography | 1 | 2025 | 166 | 0.820 |
Why?
|
| Aortic Coarctation | 2 | 2023 | 35 | 0.810 |
Why?
|
| Vasodilator Agents | 1 | 2023 | 151 | 0.760 |
Why?
|
| Anesthesia, General | 1 | 2023 | 127 | 0.740 |
Why?
|
| Tetralogy of Fallot | 2 | 2020 | 45 | 0.730 |
Why?
|
| Echocardiography | 4 | 2024 | 1004 | 0.690 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2024 | 3639 | 0.690 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2021 | 70 | 0.680 |
Why?
|
| Contrast Media | 1 | 2025 | 1096 | 0.650 |
Why?
|
| Education, Distance | 1 | 2020 | 25 | 0.650 |
Why?
|
| Pulmonary Atresia | 1 | 2020 | 12 | 0.650 |
Why?
|
| Adenosine | 1 | 2023 | 278 | 0.640 |
Why?
|
| Cardiology | 1 | 2020 | 130 | 0.600 |
Why?
|
| Chloral Hydrate | 1 | 2019 | 3 | 0.600 |
Why?
|
| Pentobarbital | 1 | 2019 | 19 | 0.600 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 145 | 0.590 |
Why?
|
| Angioplasty, Balloon | 1 | 2019 | 98 | 0.590 |
Why?
|
| Infant | 6 | 2025 | 3360 | 0.580 |
Why?
|
| Conscious Sedation | 1 | 2019 | 78 | 0.570 |
Why?
|
| Child, Preschool | 7 | 2025 | 3970 | 0.540 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 142 | 0.530 |
Why?
|
| Child | 10 | 2025 | 7618 | 0.520 |
Why?
|
| Systemic Inflammatory Response Syndrome | 3 | 2021 | 60 | 0.520 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2020 | 514 | 0.500 |
Why?
|
| Predictive Value of Tests | 4 | 2025 | 1805 | 0.500 |
Why?
|
| Stents | 1 | 2019 | 422 | 0.500 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 436 | 0.490 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2015 | 172 | 0.480 |
Why?
|
| Pediatrics | 1 | 2020 | 399 | 0.480 |
Why?
|
| Pulmonary Artery | 2 | 2013 | 340 | 0.420 |
Why?
|
| Heart Failure | 1 | 2024 | 1422 | 0.420 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2013 | 43 | 0.400 |
Why?
|
| Infant, Newborn | 3 | 2025 | 2611 | 0.380 |
Why?
|
| Heart Bypass, Right | 1 | 2010 | 12 | 0.330 |
Why?
|
| Fontan Procedure | 1 | 2010 | 56 | 0.310 |
Why?
|
| Retrospective Studies | 9 | 2023 | 10273 | 0.280 |
Why?
|
| Humans | 23 | 2025 | 95802 | 0.280 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2021 | 340 | 0.280 |
Why?
|
| Age Factors | 2 | 2025 | 1957 | 0.280 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 777 | 0.260 |
Why?
|
| Administration, Intravenous | 1 | 2025 | 66 | 0.230 |
Why?
|
| Radiation Exposure | 1 | 2025 | 25 | 0.230 |
Why?
|
| Cardiac Output, High | 1 | 2024 | 3 | 0.220 |
Why?
|
| Radiation Dosage | 1 | 2025 | 235 | 0.220 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2024 | 107 | 0.210 |
Why?
|
| Female | 14 | 2024 | 49872 | 0.200 |
Why?
|
| Endocarditis | 1 | 2022 | 25 | 0.190 |
Why?
|
| Male | 12 | 2024 | 45686 | 0.180 |
Why?
|
| Adolescent | 6 | 2023 | 9873 | 0.180 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 27 | 0.180 |
Why?
|
| Coronary Aneurysm | 1 | 2021 | 16 | 0.180 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2021 | 9 | 0.170 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 11 | 0.160 |
Why?
|
| Azithromycin | 1 | 2020 | 17 | 0.160 |
Why?
|
| Collateral Circulation | 1 | 2020 | 40 | 0.160 |
Why?
|
| Long QT Syndrome | 1 | 2020 | 39 | 0.160 |
Why?
|
| Needs Assessment | 1 | 2020 | 171 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2025 | 2480 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2020 | 206 | 0.140 |
Why?
|
| Risk Factors | 3 | 2025 | 5961 | 0.140 |
Why?
|
| Thrombosis | 1 | 2021 | 326 | 0.140 |
Why?
|
| Electrocardiography | 1 | 2020 | 522 | 0.130 |
Why?
|
| Gadolinium | 1 | 2017 | 106 | 0.130 |
Why?
|
| Sarcoidosis | 1 | 2017 | 75 | 0.130 |
Why?
|
| Young Adult | 6 | 2024 | 7026 | 0.120 |
Why?
|
| Curriculum | 1 | 2020 | 615 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2021 | 766 | 0.120 |
Why?
|
| Computer Systems | 1 | 2015 | 79 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 346 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 334 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2015 | 170 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 880 | 0.100 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2013 | 12 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 285 | 0.100 |
Why?
|
| Pulmonary Valve | 1 | 2013 | 33 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 2773 | 0.100 |
Why?
|
| India | 2 | 2011 | 138 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2859 | 0.090 |
Why?
|
| Exercise | 1 | 2015 | 355 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 197 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2013 | 167 | 0.090 |
Why?
|
| Chest Tubes | 1 | 2010 | 21 | 0.080 |
Why?
|
| Developing Countries | 1 | 2011 | 91 | 0.080 |
Why?
|
| Pleural Effusion | 1 | 2010 | 43 | 0.080 |
Why?
|
| Adult | 7 | 2024 | 28578 | 0.080 |
Why?
|
| Exercise Tolerance | 1 | 2010 | 66 | 0.080 |
Why?
|
| Warfarin | 1 | 2010 | 107 | 0.080 |
Why?
|
| Drainage | 1 | 2010 | 172 | 0.070 |
Why?
|
| Aspirin | 1 | 2010 | 169 | 0.070 |
Why?
|
| Algorithms | 1 | 2017 | 2015 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 180 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 787 | 0.070 |
Why?
|
| Ventricular Function, Left | 2 | 2021 | 662 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2010 | 463 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2010 | 926 | 0.060 |
Why?
|
| Prognosis | 2 | 2024 | 3990 | 0.060 |
Why?
|
| Oxygen | 1 | 2010 | 781 | 0.060 |
Why?
|
| Time Factors | 2 | 2011 | 5561 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 28208 | 0.050 |
Why?
|
| Aorta | 1 | 2023 | 294 | 0.040 |
Why?
|
| Cardiotoxicity | 1 | 2021 | 12 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2023 | 273 | 0.040 |
Why?
|
| Myocarditis | 1 | 2021 | 58 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2021 | 65 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2022 | 362 | 0.040 |
Why?
|
| New York City | 1 | 2020 | 69 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2011 | 9167 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 20848 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 79 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2020 | 96 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2021 | 201 | 0.040 |
Why?
|
| Heart | 1 | 2021 | 590 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1176 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 284 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 1615 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1714 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 3237 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1208 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 816 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 823 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 362 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 2385 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 707 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 423 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 447 | 0.020 |
Why?
|
| Length of Stay | 1 | 2011 | 833 | 0.020 |
Why?
|